Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
39 hedge funds and large institutions have $39.6M invested in Alimera Sciences in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 10 closing their positions.
18% more capital invested
Capital invested by funds: $33.6M → $39.6M (+$6.06M)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
17% less funds holding
Funds holding: 47 → 39 (-8)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$2.26M |
| 2 |
AC
Armistice Capital
New York
|
+$1.59M |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$1.07M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$449K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.62M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.48M |
| 3 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$1.87M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.09M |
| 5 |
Goldman Sachs
New York
|
-$391K |
ALIM Hedge Fund Activity: Q1 2017 in Review
39 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2017, worth a combined $39.6M — up 18% from $33.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ALIM and 6 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 10 added.
The largest buyer was Avoro Capital Advisors, adding an estimated $2.26M. The largest seller was Stonepine Capital Management, cutting an estimated $2.62M.
- 39 institutional investors held Alimera Sciences (ALIM) as of Q1 2017, down from 47 in Q4 2016.
- Funds reported $39.6M of Alimera Sciences stock for Q1 2017, up 18% quarter-over-quarter.
- 6 funds opened new Alimera Sciences positions in Q1 2017 and 10 closed out, a net change of -4 holders.
- The largest Alimera Sciences buyer in Q1 2017 was Avoro Capital Advisors, an estimated $2.26M added.
- The largest Alimera Sciences seller in Q1 2017 was Stonepine Capital Management, an estimated $2.62M sold.
Based on aggregated 13F filings for Q1 2017.